RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
29.60
-0.73 (-2.41%)
Feb 21, 2025, 4:00 PM EST - Market closed
RxSight Revenue
RxSight had revenue of $35.31M in the quarter ending September 30, 2024, with 59.08% growth. This brings the company's revenue in the last twelve months to $128.29M, up 67.52% year-over-year. In the year 2023, RxSight had annual revenue of $89.08M with 81.77% growth.
Revenue (ttm)
$128.29M
Revenue Growth
+67.52%
P/S Ratio
8.71
Revenue / Employee
$343,029
Employees
374
Market Cap
1.19B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
RXST News
- 5 weeks ago - RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance - GlobeNewsWire
- 7 weeks ago - RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference - GlobeNewsWire
- 3 months ago - RxSight's Momentum In The Large Cataract Surgery Market Merits A Close Eye - Seeking Alpha
- 3 months ago - RxSight, Inc. (RXST) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - RxSight, Inc. to Report Third Quarter Financial Results on November 7, 2024 - GlobeNewsWire
- 6 months ago - RxSight, Inc. to Participate in Upcoming Morgan Stanley and Wells Fargo Healthcare Conferences - GlobeNewsWire
- 6 months ago - Investing In The Future Of Cataract Surgery: The RxSight Advantage - Seeking Alpha
- 7 months ago - RxSight, Inc. (RXST) Q2 2024 Earnings Call Transcript - Seeking Alpha